Bank of New York Mellon
FRTX

Bank of New York Mellon’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bank of New York Mellon’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,341
Closed -$8K – 4614
2022
Q2 		$8K Hold
1,341
– – ﹤0.01% 4564
2022
Q1 		$16K Hold
1,341
– – ﹤0.01% 4626
2021
Q4 		$14K Hold
1,341
– – ﹤0.01% 4606
2021
Q3 		$43K Hold
1,341
– – ﹤0.01% 4455
2021
Q2 		$57K Hold
1,341
– – ﹤0.01% 4309
2021
Q1 		$66K Buy
+1,341
New +$73.6K ﹤0.01% 4220
2018
Q2 		– Sell
-36
Closed -$16K – 4326
2018
Q1 		$16K Buy
+36
New +$17.9K ﹤0.01% 4281
2017
Q2 		– Sell
-37
Closed -$26K – 4361
2017
Q1 		$26K Buy
+37
New +$26.1K ﹤0.01% 4209
2016
Q3 		– Sell
-34
Closed -$48K – 4325
2016
Q2 		$48K Buy
34
+2
+6% +$2.57K ﹤0.01% 4182
2016
Q1 		$40K Hold
32
– – ﹤0.01% 4106
2015
Q4 		$42K Sell
32
-2
-6% -$2.61K ﹤0.01% 4212
2015
Q3 		$49K Buy
34
+2
+6% +$3.86K ﹤0.01% 4241
2015
Q2 		$71K Buy
32
+4
+14% +$12.5K ﹤0.01% 4114
2015
Q1 		$85K Hold
28
– – ﹤0.01% 4074
2014
Q4 		$94K Hold
28
– – ﹤0.01% 4056
2014
Q3 		$100K Hold
28
– – ﹤0.01% 4052
2014
Q2 		$109K Sell
28
-78
-74% -$293K ﹤0.01% 3979
2014
Q1 		$431K Sell
106
-3
-3% -$13.4K ﹤0.01% 3628
2013
Q4 		$405K Buy
109
+3
+3% +$11.4K ﹤0.01% 3651
2013
Q3 		$417K Buy
106
+2
+2% +$15K ﹤0.01% 3582
2013
Q2 		$1.03M Buy
+104
New +$1.15M ﹤0.01% 3177

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon's FRTX Position: Q3 2022 in Review

Bank of New York Mellon sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 1,341 shares — an estimated $8K sold.

Bank of New York Mellon first reported a position in FRTX in Q2 2013 and held it in 21 quarters. The position peaked at $1.03M in Q2 2013. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

  • Bank of New York Mellon reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 1,341 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $8K.
  • Bank of New York Mellon first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Bank of New York Mellon's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $1.03M in Q2 2013.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.